Amphastar Pharmaceuticals Inc.

05/07/2021 | Press release | Distributed by Public on 05/07/2021 14:11

Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin Subsidiary